Concepedia

C. Souppart

CS

Statistics

Publications

19

Citations

831

H-Index

16

Active since

1976

Affiliations

Novartis (Switzerland)(Current)

Novartis (France)

C. Souppart is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and drug analysis.

Top concepts

Publications per year

1976–2006

19

Publications

19

Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara<sup>®</sup>) in breast cancer patients

C. Pfister, Antonio Martoni, Carlo Zamagni et al. · Biopharmaceutics & Drug Disposition · 2001 · 98 citations

Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography

J. B. Lecaillon, M.C. Rouan, C. Souppart et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1982 · 92 citations

, , +9

Development and validation of a high-performance liquid chromatography–mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma

C. Souppart, N. Gauducheau, N. Sandrenan et al. · Journal of Chromatography B · 2002 · 85 citations

, , +9

Pharmacokinetics and electrocardiographic pharmacodynamics of artemether‐lumefantrine (Riamet<sup>®</sup>) with concomitant administration of ketoconazole in healthy subjects

Gilbert Lefèvre, Polly Carpenter, C. Souppart et al. · British Journal of Clinical Pharmacology · 2002 · 83 citations · Full text

Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients

Lorenz Jost, Hans-Peter Gschwind, T. Jalava et al. · Drug Metabolism and Disposition · 2006 · 75 citations

1–5 of 19